Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.

BMC cancer - 9 Oct 2014

Camilo Vânia, Barros Rita, Celestino Ricardo, Castro Patrícia, Vieira Joana, Teixeira Manuel R, Carneiro Fátima, Pinto-de-Sousa João, David Leonor, Almeida Raquel

Abstract excerpt

BACKGROUND: Gastric cancer remains a serious health concern worldwide. Patients would greatly benefit from the discovery of new biomarkers that predict outcome more accurately and allow better treatment and follow-up decisions. Here, we used a retrospective, observational study to assess the expression and prognostic value of the transcription factors SOX2 and CDX2 in gastric cancer. METHODS: SOX2, CDX2, MUC5AC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to CDX2 Transcription Factor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Gene Amplification

Share to Kaplan-Meier Estimate

Share to Proportional Hazards Models

Share to SOXB1 Transcription Factors

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25300947
DOI: 10.1186/1471-2407-14-753
PMCID: PMC4210532

Genes

SOX2
CDX2
MUC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.PMID 25300947Read ↗

Gastric Adenocarcinomas with CDX2 Induction Show Higher Frequency of TP53 and KMT2B Mutations and MYC Amplifications but Similar Survival Compared with Cancers with No CDX2 InductionSemantic proximity Read ↗

Sox2 expression in human stomach adenocarcinomas with gastric and gastric‐and‐intestinal‐mixed phenotypesSemantic proximity Read ↗

The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cellsSemantic proximity Read ↗

Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor PrognosisSemantic proximity Read ↗

CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.Semantic proximity Read ↗

Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancerSemantic proximity Read ↗

Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma.Semantic proximity Read ↗

Sox2 expression is maintained while gastric phenotype is completely lost in Cdx2-induced intestinal metaplastic mucosa.Semantic proximity Read ↗

Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic CancerSemantic proximity Read ↗

Clinical Significance of LncRNAs SOX2-OT and NEAT1 in Esophageal Squamous Cell CarcinomaSemantic proximity Read ↗

Association of lncRNA SOX2OT rs9839776 polymorphism with gastric cancer risk in Korean: Case-control study.Semantic proximity Read ↗

FOXF2-Mediated lncRNA LINC02532 Promotes Gastric Cancer Cell Migration and Invasion By Decreasing SOX7 mRNA StabilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.